NAD+

Nicotinamide adenine dinucleotide (NAD+) is an important molecule found in every living cell, and it plays a role in helping the body make energy. It works by moving electrons between molecules during chemical reactions, which is necessary for cells to produce energy. But NAD+ does more than just help with energy, it’s also important for fixing damaged DNA, slowing aging, and keeping cells healthy overall. As we get older, our NAD+ levels naturally drop, which can lead to age-related diseases and weaker cell function. Because of this, raising NAD+ levels has become a major focus in research on aging and treatments that aim to help people stay healthier longer.

Category

Coenzyme and metabolic regulator

Sequence

NAD+ consists of two nucleotides joined through their phosphate groups. One nucleotide contains an adenine base, and the other contains nicotinamide

Molecular Weight

Approximately 663.43 g/mol

Molecular Formula

C21H27N7O14P2

Half Life

Approximately 1–4 hours intracellularly, with variations by cellular compartment (cytoplasmic: ~2 hours; mitochondrial: ~4–6 hours)

Most Common Uses

Nicotinamide adenine dinucleotide (NAD+) is a natural substance found in all living cells, plays an important role in many bodily functions, and its possible health benefits are being studied more and more. Taking NAD+ supplements, often through related compounds like nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), is being looked at as a way to keep cells healthy and help with age-related issues. People often use it to boost their energy levels, since NAD+ helps cells make energy (ATP) in the mitochondria. This may help reduce tiredness and improve physical ability, especially in older adults.

Research also shows that NAD+ helps activate proteins called sirtuins, which play a role in fixing damaged DNA and keeping cells healthy longer. Because of this, it’s being studied for its potential to slow down aging. NAD+ is also being looked at for protecting the brain, with some studies suggesting it could help with memory and reduce brain damage in conditions like Alzheimer’s disease or after head injuries. When it comes to metabolism, taking NAD+ supplements might improve how the body uses insulin and help manage problems like diabetes or obesity. Some early research and personal stories also suggest it could help people recovering from addiction, since NAD+ infusions might ease withdrawal symptoms and reduce cravings by helping cells heal. Although early studies in animals and people are encouraging, larger clinical trials are still underway to confirm how well NAD+ works and the best ways to use it.

History of NAD+

In 1906, British biochemists Arthur Harden and William John Young found that adding boiled yeast extract to unboiled yeast sped up alcohol production. They called the mysterious substance responsible a “coferment.” Later, in the 1930s, Hans von Euler-Chelpin purified this substance and identified it as a nucleotide sugar phosphate, a key piece of NAD+. In 1936, Otto Heinrich Warburg, a German scientist, figured out that NAD+ plays an important role in chemical reactions that transfer energy in cells, specifically through its nicotinamide part. Then, in 1938, Conrad Elvehjem discovered that nicotinamide, found in liver, could prevent a disease called “black tongue” in dogs, hinting at its role in making NAD+. By 1939, Elvehjem showed that nicotinic acid, a form of vitamin B3, is used to create NAD+.

In the early 1940s, Arthur Kornberg found an enzyme involved in NAD+ production. In 1949, Morris Friedkin and Albert L. Lehninger connected NAD+ (specifically its reduced form, NADH) to energy production in processes like the citric acid cycle, which helps cells generate energy through a process called oxidative phosphorylation. In 1958, Jack Preiss and Philip Handler mapped out how NAD+ is made from nicotinic acid in what’s now called the Preiss-Handler pathway. In 2004, Charles Brenner discovered another way cells make NAD+ using nicotinamide riboside.

Scientists later learned NAD+ does more than just energy-related tasks. In the early 1960s, researchers found it helps in a process called ADP-ribosylation, which is important for cell signaling. In 1987, cyclic ADP-ribose, a molecule related to NAD+, was discovered to play a role in cell communication.

Research on NAD+ continued into the 2000s. In 2000, Shin-ichiro Imai and colleagues, working in Leonard P. Guarente’s lab, found that NAD+ works with proteins called sirtuins, which are linked to aging and longevity. In 2009, Imai proposed the “NAD World” idea, suggesting that sirtuins and an enzyme called NAMPT, which helps make NAD+, are key to controlling aging in mammals. In 2016, he updated this to “NAD World 2.0,” highlighting how NAMPT in fat tissue and muscle signals help maintain NAD+ levels in the brain’s hypothalamus, a control center for the body. In 2018, Eric Verdin’s lab inspired the creation of Napa Therapeutics, a company working on new anti-aging drugs based on NAD+ research.

Mechanism of Action

NAD+ helps many important chemical reactions in the body by carrying electrons. It exists in two forms, oxidized (NAD+) and reduced (NADH), and plays a key role in energy-related reactions inside cells. It helps make energy (ATP) in the mitochondria by taking part in processes like glycolysis, the citric acid cycle, and oxidative phosphorylation, which boosts how the body uses energy. NAD+ activates other enzymes called PARPs that fix damaged DNA, helping keep the cell’s genetic material stable. In the brain and nervous system, it helps protect nerve cells by keeping mitochondria healthy and reducing damage from harmful molecules, which may help in conditions like Alzheimer’s. It also plays a role in calcium signaling, a process important for things like insulin release and immune system function. Through all these actions, NAD+ helps keep the body’s systems in balance, supports cell repair, and makes tissues more resilient. While studies in animals and lab settings have shown strong results, researchers are still working to understand how well NAD+ treatments work in people.

Structure and Pharmacology

Nicotinamide adenine dinucleotide (NAD+) is composed of two nucleotides linked by a pyrophosphate bond, with one nucleotide containing an adenine nucleobase and the other a nicotinamide moiety. Its molecular formula is C21H27N7O14P2, and it has a molecular weight of 663.43 g/mol. The structure includes a nicotinamide ring that accepts and donates electrons, enabling NAD+ to alternate between oxidized (NAD+) and reduced (NADH) forms, facilitating redox reactions. This water-soluble molecule is stable in physiological environments but can be degraded by enzymes like CD38 and PARPs. NAD+ is not typically administered directly due to poor cellular uptake; instead, precursors like nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) are used to boost intracellular NAD+ levels, delivered orally, intravenously, or via subcutaneous injection.

Pharmacologically, NAD+ exhibits rapid turnover, with intracellular half-lives of approximately 1–4 hours in mammalian cells, varying by compartment (cytoplasmic: ~2 hours; mitochondrial: ~4–6 hours). Precursors like NMN and NR are absorbed efficiently in the gastrointestinal tract and converted to NAD+ via salvage pathways, primarily in the liver, brain, and skeletal muscle. NAD+ supports energy metabolism by facilitating ATP production through glycolysis, the citric acid cycle, and oxidative phosphorylation. It acts as a substrate for sirtuins, promoting DNA repair and cellular longevity, and for poly(ADP-ribose) polymerases (PARPs), aiding DNA damage repair.

NAD+ also contributes to calcium signaling via cyclic ADP-ribose synthesis, influencing insulin secretion and immune responses. Metabolism involves enzymatic cleavage by NAD+-consuming enzymes, yielding nicotinamide, which is recycled or excreted renally. While preclinical studies demonstrate NAD+’s role in metabolic and neuroprotective processes, human pharmacokinetic data are limited, with ongoing research exploring optimal delivery methods and therapeutic applications.

Dosages

This peptide is not typically administered directly due to limited cellular uptake, so dosages are often based on its precursors, nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), derived from preclinical studies, clinical trials, and anecdotal reports. In human studies, NMN is commonly administered orally at doses ranging from 100 to 1000 milligrams per day, with 250 to 500 milligrams daily being typical for supporting metabolic health and cellular repair. NR is similarly dosed, with oral administration ranging from 100 to 2000 milligrams daily, often starting at 300 milligrams to enhance energy metabolism and cognitive function.

Intravenous NAD+ infusions, used in some clinical settings for addiction recovery or neuroprotection, typically range from 500 to 2000 milligrams per session, administered over several hours, with treatment protocols varying from single doses to multiple sessions over days or weeks. Dosing frequency depends on the therapeutic goal, with daily oral supplementation common for NMN and NR, while infusions may occur weekly or as part of intensive regimens.

Due to limited standardized guidelines and regulatory approval, users often adjust doses based on individual response under medical supervision. Some anectodal reports suggest that starting dose of NAD+ can be 25mg dosed 2 times weekly, but can be titrated up as needed.

Warnings and Cautions

NAD+ supplementation lacks comprehensive regulatory approval for therapeutic use in many regions, and its safety profile in humans remains under investigation due to limited large-scale clinical trials. Long-term effects of high-dose supplementation are not fully understood, and excessive intake may lead to unforeseen adverse effects. Pregnant or breastfeeding women should avoid NAD+ precursors, as safety data in these populations are absent. Intravenous NAD+ infusions, often used in specialized clinics, require sterile administration by trained professionals to prevent infections or complications.

Some users report mild side effects, including nausea, headache, or flushing, particularly with high oral doses or infusions, though systematic data on adverse reactions are limited. Sourcing NAD+ precursors from unregulated suppliers increases the risk of receiving impure or mislabeled products, which could cause harm. While preclinical studies and early human trials suggest benefits, the lack of robust long-term human data necessitates caution. Ongoing research continues to explore the safety and therapeutic potential of NAD+ supplementation.

Research & Clinical Trials

Boosting Molecules

Helps with Alzheimer’s Disease

NAD+ Metabolism in Health and Disease

Effect of Oral Administration of Nicotinamide Mononucleotide

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

References

[1] Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell metabolism, 27(3), 529–547. https://doi.org/10.1016/j.cmet.2018.02.011

[2] Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D. L., Zavala, E., Zhang, Y., Moritoh, K., O'Connell, J. F., Baptiste, B. A., Stevnsner, T. V., Mattson, M. P., & Bohr, V. A. (2018). NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proceedings of the National Academy of Sciences of the United States of America, 115(8), E1876–E1885. https://doi.org/10.1073/pnas.1718819115

[3] Belenky, P., Bogan, K. L., & Brenner, C. (2007). NAD+ metabolism in health and disease. Trends in biochemical sciences, 32(1), 12–19. https://doi.org/10.1016/j.tibs.2006.11.006

[4] Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., Yamashita, K., Shigaki, S., Ono, T., Yukioka, H., Okano, H., Nabeshima, Y. I., Imai, S. I., Yasui, M., Tsubota, K., & Itoh, H. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine journal, 67(2), 153–160. https://doi.org/10.1507/endocrj.EJ19-0313

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?